Correlation of serum fibroblast growth factor-23 levels and calcium phosphate products levels in chronic kidney disease; sub analysis of chronic kidney disease-mineral and bone disorder study

Correlation of serum fibroblast growth factor-23 levels and calcium phosphate products levels in chronic kidney disease; sub analysis of chronic kidney disease-mineral and bone disorder study

Introduction: The body produces fibroblast growth factor-23 (FGF-23) to maintain normal phosphate levels when hyperphosphatemia occurs. Production of FGF-23 indirectly causes hypocalcemia. Phosphate and calcium disturbances also occur in chronic kidney disease (CKD), therefore this adaptation mechan...

Full description

Saved in:
Bibliographic Details
Main Authors: Adeh Mahardika, Hasyim Kasim, Syakib Bakri, Haerani Rasyid, Husaini Umar, Nu’man AS Daud, Wasis Udaya, Arifin Seweng
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2024-08-01
Series:Journal of Nephropathology
Subjects:
fibroblast growth factor-23
calcium
phosphate
chronic kidney disease
ckd-mbd
Online Access:https://nephropathol.com/PDF/jnp-13-e20416.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://nephropathol.com/PDF/jnp-13-e20416.pdf

Similar Items